Analystreport

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong sell" rating. They now have

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com